OrthoPediatrics Corp. (KIDS)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 71 | 98 | 122 | 149 | 205 | 236 | 253 | 267 |
| Operating profit | $m | -29 | -23 | ||||||
| Net profit | $m | -33 | -16 | 1 | -21 | -38 | -40 | -40 | -29 |
| EPS reported | $ | -1.69 | -1.68 | ||||||
| Operating cashflow per share | $ | -0.21 | 0.31 | ||||||
| Capex per share | $ | 0.47 | 0.39 | ||||||
| FCF per share | $ | -0.68 | -0.08 | ||||||
| Free cash flow | $m | -16 | -2 | ||||||
| Net debt | $m | 39 | 46 | ||||||
| Book value equity | $m | 347 | 344 | ||||||
| Book value per share | $ | 14.77 | 14.40 | ||||||
| Number of shares | m | 23.46 | 23.87 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 1.20 | 1.21 | ||||||
| P/S LTM | x | 1.76 | 1.65 | ||||||
| P/FCF LTM | x | -26.10 | -227.05 | ||||||
| EV/EBITDA LTM | x | -41.62 | -48.50 | ||||||
| EV/Sales LTM | x | 2.10 | 2.82 | ||||||
| Earnings Yield LTM | % | -9.52% | -6.71% | ||||||
| FCF Yield | % | -3.83% | -0.44% | ||||||
| Quality | |||||||||
| ROE | % | -11.44% | -11.53% | ||||||
| ROIC | % | -6.27% | -4.97% | ||||||
| Operating margin | % | -12.27% | -9.01% | ||||||
| Gross margin | % | +73.05% | +73.65% | ||||||
| FCF/Sales | % | -6.75% | -0.73% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +15.45% | +23.44% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -0.16 | -0.02 | ||||||
| Net Debt/EBITDA | x | -6.73 | -7.28 | ||||||
| EBIT/Net interest | x | -4.84 | -2.72 | ||||||
| Net debt/market cap | % | +24.00% | +14.38% | ||||||
| Net debt/Equity | x | 0.11 | 0.13 | ||||||
| Gross debt/equity | x | 0.29 | 0.27 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free